Annual accounts receivable:
$2.56B+$330.00M(+14.81%)Summary
- As of today (May 29, 2025), BSX annual accounts receivable is $2.56 billion, with the most recent change of +$330.00 million (+14.81%) on December 31, 2024.
- During the last 3 years, BSX annual accounts receivable has risen by +$780.00 million (+43.87%).
- BSX annual accounts receivable is now at all-time high.
Performance
BSX Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$2.69B+$135.00M(+5.28%)Summary
- As of today (May 29, 2025), BSX quarterly accounts receivable is $2.69 billion, with the most recent change of +$135.00 million (+5.28%) on March 31, 2025.
- Over the past year, BSX quarterly accounts receivable has increased by +$389.00 million (+16.88%).
- BSX quarterly accounts receivable is now at all-time high.
Performance
BSX Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BSX Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.8% | +16.9% |
| 3 y3 years | +43.9% | +44.3% |
| 5 y5 years | +39.9% | +70.8% |
BSX Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.9% | at high | +44.3% |
| 5 y | 5-year | at high | +67.1% | at high | +84.8% |
| alltime | all time | at high | +3310.7% | at high | +3490.7% |
BSX Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.69B(+5.3%) |
| Dec 2024 | $2.56B(+14.8%) | $2.56B(+2.3%) |
| Sep 2024 | - | $2.50B(+4.2%) |
| Jun 2024 | - | $2.40B(+4.2%) |
| Mar 2024 | - | $2.30B(+3.4%) |
| Dec 2023 | $2.23B(+13.1%) | $2.23B(+6.0%) |
| Sep 2023 | - | $2.10B(-1.5%) |
| Jun 2023 | - | $2.13B(+2.8%) |
| Mar 2023 | - | $2.08B(+5.4%) |
| Dec 2022 | $1.97B(+10.8%) | $1.97B(+5.3%) |
| Sep 2022 | - | $1.87B(-2.4%) |
| Jun 2022 | - | $1.92B(+2.7%) |
| Mar 2022 | - | $1.87B(+4.9%) |
| Dec 2021 | $1.78B(+16.1%) | $1.78B(+6.5%) |
| Sep 2021 | - | $1.67B(-0.4%) |
| Jun 2021 | - | $1.68B(+2.7%) |
| Mar 2021 | - | $1.63B(+6.5%) |
| Dec 2020 | $1.53B(-16.2%) | $1.53B(-4.2%) |
| Sep 2020 | - | $1.60B(+9.7%) |
| Jun 2020 | - | $1.46B(-7.6%) |
| Mar 2020 | - | $1.58B(-13.7%) |
| Dec 2019 | $1.83B(+13.7%) | $1.83B(+1.8%) |
| Sep 2019 | - | $1.80B(+4.9%) |
| Jun 2019 | - | $1.71B(+5.6%) |
| Mar 2019 | - | $1.62B(+0.8%) |
| Dec 2018 | $1.61B(+3.9%) | $1.61B(+1.8%) |
| Sep 2018 | - | $1.58B(-0.4%) |
| Jun 2018 | - | $1.59B(+0.4%) |
| Mar 2018 | - | $1.58B(+2.1%) |
| Dec 2017 | $1.55B(+5.2%) | $1.55B(+5.3%) |
| Sep 2017 | - | $1.47B(+1.8%) |
| Jun 2017 | - | $1.44B(+1.0%) |
| Mar 2017 | - | $1.43B(-2.9%) |
| Dec 2016 | $1.47B(+15.5%) | $1.47B(+6.3%) |
| Sep 2016 | - | $1.39B(-0.1%) |
| Jun 2016 | - | $1.39B(+7.4%) |
| Mar 2016 | - | $1.29B(+1.3%) |
| Dec 2015 | $1.27B(+7.8%) | $1.27B(+0.1%) |
| Sep 2015 | - | $1.27B(+6.6%) |
| Jun 2015 | - | $1.20B(+2.9%) |
| Mar 2015 | - | $1.16B(-1.9%) |
| Dec 2014 | $1.18B(-9.5%) | $1.18B(-4.1%) |
| Sep 2014 | - | $1.23B(-4.2%) |
| Jun 2014 | - | $1.29B(+5.8%) |
| Mar 2014 | - | $1.22B(-6.9%) |
| Dec 2013 | $1.31B | $1.31B(+5.6%) |
| Sep 2013 | - | $1.24B(-3.1%) |
| Jun 2013 | - | $1.28B(+3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $1.23B(+1.2%) |
| Dec 2012 | $1.22B(-2.3%) | $1.22B(+1.7%) |
| Sep 2012 | - | $1.20B(-3.7%) |
| Jun 2012 | - | $1.24B(-5.5%) |
| Mar 2012 | - | $1.32B(+5.6%) |
| Dec 2011 | $1.25B(-5.6%) | $1.25B(+0.7%) |
| Sep 2011 | - | $1.24B(-7.3%) |
| Jun 2011 | - | $1.33B(-0.1%) |
| Mar 2011 | - | $1.34B(+1.2%) |
| Dec 2010 | $1.32B(-4.0%) | $1.32B(+0.4%) |
| Jun 2010 | - | $1.31B(+1.1%) |
| Mar 2010 | - | $1.30B(-5.4%) |
| Dec 2009 | $1.38B(-1.9%) | $1.38B(-3.9%) |
| Sep 2009 | - | $1.43B(-0.9%) |
| Jun 2009 | - | $1.44B(+5.5%) |
| Mar 2009 | - | $1.37B(-2.4%) |
| Dec 2008 | $1.40B(-6.7%) | $1.40B(+3.5%) |
| Sep 2008 | - | $1.35B(-4.3%) |
| Jun 2008 | - | $1.42B(-5.3%) |
| Mar 2008 | - | $1.50B(-0.4%) |
| Dec 2007 | $1.50B(+7.4%) | $1.50B(+1.0%) |
| Sep 2007 | - | $1.49B(-1.4%) |
| Jun 2007 | - | $1.51B(+5.1%) |
| Mar 2007 | - | $1.44B(+2.6%) |
| Dec 2006 | $1.40B(+50.0%) | $1.40B(-4.2%) |
| Sep 2006 | - | $1.46B(-3.9%) |
| Jun 2006 | - | $1.52B(+55.3%) |
| Mar 2006 | - | $978.00M(+4.9%) |
| Dec 2005 | $932.00M(+3.6%) | $932.00M(-2.0%) |
| Sep 2005 | - | $951.00M(-2.6%) |
| Jun 2005 | - | $976.00M(+2.4%) |
| Mar 2005 | - | $953.00M(+5.9%) |
| Dec 2004 | $900.00M(+66.1%) | $900.00M(+6.4%) |
| Sep 2004 | - | $846.00M(+3.9%) |
| Jun 2004 | - | $814.00M(+20.6%) |
| Mar 2004 | - | $675.00M(+24.5%) |
| Dec 2003 | $542.00M(+24.6%) | $542.00M(+6.7%) |
| Sep 2003 | - | $508.00M(+6.3%) |
| Jun 2003 | - | $478.00M(+5.8%) |
| Mar 2003 | - | $452.00M(+3.9%) |
| Dec 2002 | $435.00M(+17.6%) | $435.00M(+9.0%) |
| Sep 2002 | - | $399.00M(-1.7%) |
| Jun 2002 | - | $406.00M(+7.1%) |
| Mar 2002 | - | $379.00M(+2.4%) |
| Dec 2001 | $370.00M(+393.3%) | $370.00M(-5.4%) |
| Sep 2001 | - | $391.00M(+3.7%) |
| Jun 2001 | - | $377.00M(+1.9%) |
| Mar 2001 | - | $370.00M(+393.3%) |
| Dec 1994 | $75.00M | $75.00M |
FAQ
- What is Boston Scientific annual accounts receivable?
- What is the all time high annual accounts receivable for Boston Scientific?
- What is Boston Scientific annual accounts receivable year-on-year change?
- What is Boston Scientific quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Boston Scientific?
- What is Boston Scientific quarterly accounts receivable year-on-year change?
What is Boston Scientific annual accounts receivable?
The current annual accounts receivable of BSX is $2.56B
What is the all time high annual accounts receivable for Boston Scientific?
Boston Scientific all-time high annual accounts receivable is $2.56B
What is Boston Scientific annual accounts receivable year-on-year change?
Over the past year, BSX annual accounts receivable has changed by +$330.00M (+14.81%)
What is Boston Scientific quarterly accounts receivable?
The current quarterly accounts receivable of BSX is $2.69B
What is the all time high quarterly accounts receivable for Boston Scientific?
Boston Scientific all-time high quarterly accounts receivable is $2.69B
What is Boston Scientific quarterly accounts receivable year-on-year change?
Over the past year, BSX quarterly accounts receivable has changed by +$389.00M (+16.88%)